Lifeward names new board chair, three directors

Lifeward Ltd. (LFWD) reported changes to its Board of Directors.

Rhea-AI Filing Summary

Lifeward Ltd. (LFWD) reported changes to its Board of Directors. On August 14, 2026, the Board appointed Yonason Greenwald and Haggai Zamir as Class III Directors, with initial terms expiring at the 2026 Annual Meeting of Shareholders. Mr. Greenwald will serve on the Audit, Compensation, and Nominating and Corporate Governance Committees, and Mr. Zamir will serve on the Nominating and Corporate Governance Committee.

On August 20, 2026, the Board appointed Avraham Gabay as a Class III Director and Chair of the Board, also with a term expiring at the 2026 Annual Meeting. All three will receive the company’s standard non-employee director compensation. On the same date, Nadav Kidron resigned from the Board, effective immediately; the company states his departure did not result from any disagreement regarding operations, policies, or practices.

8-K Event Classification

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

1 item

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Key Figures

Board appointment date: August 14, 2026 Additional appointment and resignation date: August 20, 2026 Annual meeting term end: 2026 +1 more

4 metrics

Board appointment date August 14, 2026 Date the Board appointed Yonason Greenwald and Haggai Zamir as Class III Directors

Additional appointment and resignation date August 20, 2026 Date the Board appointed Avraham Gabay as Class III Director and Chair and Nadav Kidron resigned

Annual meeting term end 2026 Year of the Annual Meeting of Shareholders when the initial Class III Director terms expire

Company phone number +508.251.1154 Registrant’s telephone number listed for Lifeward Ltd.

Key Terms

Class III Director, Audit Committee, Compensation Committee, Nominating and Corporate Governance Committee, +1 more

5 terms

Class III Director regulatory

"appointed Yonason Greenwald and Haggai Zamir, each to serve as a Class III Director"

A Class III director is a board member placed in one of the numbered groups used by companies with a staggered (or “classified”) board; that director’s seat typically comes up for election in the third year of a three-year rotation. For investors this matters because staggered terms create continuity but also make it harder to replace the whole board quickly, affecting shareholder influence, takeover dynamics and how fast new strategy or accountability can be implemented — like replacing only some players on a sports team each season instead of the whole roster at once.

Audit Committee financial

"Mr. Greenwald will serve as a member of each of the Audit Committee"

A company's audit committee is a small group of board members who act like independent inspectors for the firm's finances, overseeing how financial reports are prepared, monitoring internal controls, and managing the relationship with external auditors. Investors care because a strong audit committee reduces the risk of accounting errors, fraud, or misleading statements, making financial statements more trustworthy and helping protect shareholder value.

Compensation Committee financial

"Mr. Greenwald will serve as a member of each of the Audit Committee, Compensation Committee"

A compensation committee is a group within a company's leadership responsible for setting and reviewing how much top executives and employees are paid, including salaries, bonuses, and benefits. It matters to investors because fair and effective pay decisions can influence a company's performance, leadership motivation, and overall governance, helping ensure that the company’s management is aligned with shareholders’ interests.

Nominating and Corporate Governance Committee regulatory

"and Nominating and Corporate Governance Committee and Mr. Zamir will serve"

A nominating and corporate governance committee is a group within a company's board of directors responsible for selecting and recommending individuals to serve as company leaders, such as directors or executives. They also develop and oversee policies to ensure the company is run fairly, ethically, and transparently. This committee matters to investors because it helps ensure the company is well-managed and guided by qualified, responsible leadership.

Item 404(a) of Regulation S-K regulatory

"no transactions in which Mr. Greenwald, Mr. Zamir or Mr. Gabay have an interest requiring disclosure under Item 404(a) of Regulation S-K"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What board changes did Lifeward Ltd. (LFWD) announce in this 8-K?

Lifeward Ltd. appointed Yonason Greenwald, Haggai Zamir, and Avraham Gabay as Class III Directors, with Mr. Gabay also becoming Chair of the Board, and reported the resignation of director Nadav Kidron, effective August 20, 2026.

What are the terms of the new Lifeward (LFWD) directors’ appointments?

The Board appointed Yonason Greenwald, Haggai Zamir, and Avraham Gabay as Class III Directors, each with an initial term expiring at Lifeward’s 2026 Annual Meeting of Shareholders.

Which board committees will the new Lifeward (LFWD) directors serve on?

Yonason Greenwald will serve on the Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee. Haggai Zamir will serve on the Nominating and Corporate Governance Committee. Avraham Gabay will serve as Chair of the Board.

Did Lifeward (LFWD) disclose any disagreements related to Nadav Kidron’s resignation?

No. Lifeward states that Nadav Kidron’s decision on August 20, 2026 to step down from the Board, effective immediately, did not result from any disagreement with the company regarding its operations, policies, or practices.

How will the new Lifeward (LFWD) directors be compensated?

Each of Yonason Greenwald, Haggai Zamir, and Avraham Gabay will receive the standard compensation for non-employee directors of Lifeward Ltd., as described in the company’s Form 10-K Director Compensation disclosure filed on March 18, 2026.

Are there any related-party transactions involving the new Lifeward (LFWD) directors?

Lifeward states there are no transactions involving Mr. Greenwald, Mr. Zamir, or Mr. Gabay requiring disclosure under Item 404(a) of Regulation S-K, and they have no family relationships with the company’s directors or executive officers.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/20/2026 - 04:05 PM EDT Learn about SEC filing dates

false000160796200-0000000NASDAQ00016079622026-08-142026-08-14

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 14, 2026

Lifeward Ltd.

(Exact name of registrant as specified in its charter)

Israel		001-36612		Not applicable
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)

2 Cabot Rd., Hudson, MA		01749
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: +508.251.1154

Not applicable

(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Exchange Act		Trading Symbol		Name of each exchange on which  registered
Ordinary shares, no par value		LFWD		Nasdaq Capital Market

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officer.

Appointment of Directors

On August 14, 2026, the Board of Directors (the “Board”) of Lifeward Ltd. (the “Company”) appointed Yonason Greenwald and Haggai Zamir, each to serve as a Class III Director, with an initial term expiring at the Company’s 2026 Annual Meeting of Shareholders. Mr. Greenwald will serve as a member of each of the Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee and Mr. Zamir will serve as a member of the Nominating and Corporate Governance Committee.

On August 20, 2026, the Board appointed Avraham Gabay to serve as a Class III Director, with an initial term expiring at the Company’s 2026 Annual Meeting of Shareholders. Mr. Gabay will also serve as Chair of the Board.

As compensation for services as a director, each of Mr. Greenwald, Mr. Zamir and Mr. Gabay will be entitled to standard compensation available to non-employee directors of the Company as disclosed under “Director Compensation” in the Company’s Annual Report on Form 10-K, filed with the Securities and Exchange Commission on March 18, 2026. There are no arrangements or understandings between each of Mr. Greenwald,   Mr. Zamir and Mr. Gabay and any other person pursuant to which each such individual was selected as a director. Other than with respect to the above-described arrangements, there are no transactions in which Mr. Greenwald, Mr. Zamir or Mr. Gabay have an interest requiring disclosure under Item 404(a) of Regulation S-K, and Mr. Greenwald, Mr. Zamir and Mr. Gabay do not have any family relationship with any director or executive officer of the Company or any person nominated or chosen by the Company to become a director or executive officer.

Resignation of Director

On August 20, 2026, Nadav Kidron notified the Board of his decision to step down from the Board, effective immediately. The departure of Mr. Kidron did not result from any disagreement with the Company on any matter relating to its operations, policies or practices. The Company extends its deepest gratitude to Mr. Kidron for his distinguished service to the Board and lasting contributions to the Company.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Lifeward Ltd.
Dated: August 20, 2026	By:	/s/ Almog Adar
	Name:	Almog Adar
	Title:	Chief Financial Officer

Filing Exhibits & Attachments

3 documents

Other Documents

• EX-101 XBRL TAXONOMY EXTENSION SCHEMA 3.8 KB
• EX-101 XBRL TAXONOMY EXTENSION LABEL LINKBASE 21.5 KB
• EX-101 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE 15.7 KB